기업 프로필 · Healthcare

Cigna Corp

CI · 미국
거래소
미국
국가 / 지역
USA
상장일
1982년 3월 31일
직원 수
65,669
현재가
$279.27
실시간 · 2026년 6월 18일
베일리 성장 점수
42/100
다소 약함
내재가치 · 3단계 구간 현재가 $279.27 실시간 · 보수적 구간과 적정 구간 사이

종합 밸류에이션 구간 · 보수적 $240–$275 / 적정 $310–$395 / 낙관적 $465–$600. $279.27 기준, 보수적 구간과 적정 구간 사이.

보고서 발행 시 $286(2026년 5월 24일)

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

시가총액US$754.16억
매출 (TTM)US$2778.92억
EBITDAUS$133.9억
순이익률2.26%
ROE16.27%
PER (TTM)11.4
선행 PER9.39
PEG0.85
EPSUS$25.01
배당수익률2.09%
52주 범위US$235.50 – US$331.55
애널리스트 목표주가US$340.50
애널리스트 평가4.3 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.